Brinter

Brinter is an American-Finnish biotech firm developing 3D bioprinted regenerative tissue implants for orthopedic and aesthetic medical applications. The company's flagship product is a tendon and ligament implant on track to become the world's first 3D-bioprinted orthopedic implant to reach commercial use. Brinter's implants are bioresorbable and engineered with biomimetic architecture and bioactive materials to support the body's natural healing cascade. The company's patented 3D bioprinter-powered manufacturing automation platform enables scalable, high-performance mass production of medical devices. Applications include orthopedic soft-tissue repair and aesthetic procedures, with a longer-term vision for organ printing.